Supplementary Figure S1 from Dual CAR-T Cells Targeting CD19 and CD37 Are Effective in Target Antigen Loss B-cell Tumor Models

Supplemental Figure S1. CD19 and CD37 expression of EBV-LCL. EBV-LCL was stained with CD19-PE and CD37-FITC mAb, respectively. Grey tinted area indicated isotype control staining.